This randomized clinical trial will evaluate the effect of tonabersat compared with placebo
on central subfield thickness (CST) in eyes with center-involved diabetic macular edema
(CI-DME) and good visual acuity.
Phase:
Phase 2
Details
Lead Sponsor:
Jaeb Center for Health Research
Collaborators:
Juvenile Diabetes Research Foundation National Eye Institute (NEI) National Institutes of Health (NIH)